COVID-19: all 7,774 studies

Page 11 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 PatientsCompletedNCT04540406Phase 2Results posted
• COVID-19 Study of Safety and Tolerability of AlvelestatCompletedNCT04539795Phase 1/2Results posted
• VA CoronavirUs Research and Efficacy Studies-1TerminatedNCT04539275Phase 3Results posted
• Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by InhalationCompletedNCT04539262Phase 1/2Results posted
• A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy AdultsCompletedNCT04537949Phase 1/2Results posted
• A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)TerminatedNCT04537806Phase 3Results posted
• Swallowing Impairment After COVID-19 InfectionCompletedNCT04537650Results posted
• COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing HomesTerminatedNCT04537299Phase 2Results posted
• Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and OlderCompletedNCT04537208Phase 1/2Results posted
• First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.CompletedNCT04535167Phase 1Results posted
• Tafenoquine in Patients With Mild to Moderate COVID-19CompletedNCT04533347Phase 2Results posted
• Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedNCT04532931Phase 2Results posted
• Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent MalignancyCompletedNCT04532372Phase 1/2Results posted
• Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy ParticipantsCompletedNCT04532294Phase 1Results posted
• Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04530604Phase 1Results posted
• Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19CompletedNCT04530136Phase 2Results posted
• Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 PatientsTerminatedNCT04529499Phase 3Results posted
• Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 VaccineCompletedNCT04528641Phase 1Results posted
• Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19CompletedNCT04527471Phase 2Results posted
• To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy SubjectsCompletedNCT04525079Phase 1Results posted
• Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 PatientsCompletedNCT04524663Phase 2Results posted
• Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized PatientsCompletedNCT04524507Phase 2Results posted
• Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 InfectionCompletedNCT04523831Phase 3Results posted
• Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized PatientsCompletedNCT04523181Phase 2Results posted
• Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 StudyCompletedNCT04520191Results posted
• ACTIV-2: A Study for Outpatients With COVID-19CompletedNCT04518410Phase 2/3Results posted
• FEnofibRate as a Metabolic INtervention for COVID-19CompletedNCT04517396Phase 2Results posted
• AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19CompletedNCT04516759Phase 2Results posted
• Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCompletedNCT04516746Phase 3Results posted
• A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19CompletedNCT04515147Phase 2Results posted
• Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) InfectionTerminatedNCT04513158Phase 2Results posted
• Losmapimod Safety and Efficacy in COVID-19TerminatedNCT04511819Phase 3Results posted
• Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019TerminatedNCT04511650Phase 2Results posted
• COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)CompletedNCT04510194Phase 3Results posted
• A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) InfectionTerminatedNCT04508023Phase 3Results posted
• Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage IIICompletedNCT04507867Not applicableResults posted
• AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19CompletedNCT04507256Phase 1Results posted
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTECompletedNCT04505774Phase 4Results posted
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult ParticipantsCompletedNCT04505722Phase 3Results posted
• Tenecteplase in Patients With COVID-19CompletedNCT04505592Phase 2Results posted
• A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)TerminatedNCT04504032Phase 2Results posted
• Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent PlasmaTerminatedNCT04502472Phase 2/3Results posted
• Covid-19 Messaging to Underserved Communities - 2nd ExperimentCompletedNCT04502056Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient SettingTerminatedNCT04501952Phase 3Results posted
• COVID-19 Project ECHO in Nursing HomesCompletedNCT04499391Not applicableResults posted
• Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19TerminatedNCT04498377Phase 2Results posted
• COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80TerminatedNCT04498273Phase 3Results posted
• A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)TerminatedNCT04498247Phase 1/2Results posted
• A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and StaffCompletedNCT04497987Phase 3Results posted
• Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19TerminatedNCT04497948Phase 1Results posted
• Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 PatientsCompletedNCT04497389Phase 1/2Results posted
• COVID-19 Anosmia StudyCompletedNCT04495816Phase 2Results posted
• A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.CompletedNCT04494984Phase 2/3Results posted
• Core Warming in COVID-19 Patients Undergoing Mechanical VentilationCompletedNCT04494867Not applicableResults posted
• BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)CompletedNCT04494646Phase 2Results posted
• Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDSCompletedNCT04493242Phase 2Results posted
• Cyclosporine For The Treatment Of COVID-19(+)CompletedNCT04492891Phase 2Results posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04492514Phase 2Results posted
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3)CompletedNCT04492475Phase 3Results posted
• COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)CompletedNCT04492410Not applicableResults posted
• Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 ProgressionCompletedNCT04491994Phase 3Results posted
• Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.CompletedNCT04491240Phase 1/2Results posted
• Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 InfectionTerminatedNCT04488575Phase 2Results posted
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)CompletedNCT04487886Phase 2Results posted
• Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19CompletedNCT04486313Phase 3Results posted
• DISulfiram for COvid-19 (DISCO) TrialTerminatedNCT04485130Phase 2Results posted
• SPI-1005 Treatment in Severe COVID-19 PatientsCompletedNCT04483973Phase 2Results posted
• Breathing Techniques and Meditation for Health Care Workers During COVID-19 PandemicActive, not recruitingNCT04482647Not applicableResults posted
• A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)CompletedNCT04481685Phase 2Results posted
• Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 InfectionCompletedNCT04481633Not applicableResults posted
• Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)CompletedNCT04480424Phase 2Results posted
• Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19TerminatedNCT04479358Phase 2Results posted
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)CompletedNCT04478071Phase 2Results posted
• Efficacy and Safety of Itolizumab in COVID-19 ComplicationsCompletedNCT04475588Phase 2Results posted
• Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated SepsisCompletedNCT04475081Phase 3Results posted
• Impact of COVID-19 on Marshallese Communities in the U.S.CompletedNCT04474496Results posted
• Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19TerminatedNCT04474483Phase 2Results posted
• KBP-201 COVID-19 Vaccine Trial in Healthy VolunteersCompletedNCT04473690Phase 1/2Results posted
• Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 PatientsTerminatedNCT04472728Phase 2/3Results posted
• Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory CompromiseTerminatedNCT04472494Phase 2Results posted
• Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)TerminatedNCT04470622Phase 2Results posted
• Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaCompletedNCT04467840Phase 2/3Results posted
• Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)CompletedNCT04466098Phase 2Results posted
• Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationCompletedNCT04463004Phase 2Results posted
• Rapid, Onsite COVID-19 DetectionCompletedNCT04460690Not applicableResults posted
• A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19CompletedNCT04460183Phase 2/3Results posted
• Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU PatientsTerminatedNCT04458948Phase 2Results posted
• Convalescent Plasma as Treatment for Subjects With Early COVID-19 InfectionTerminatedNCT04456413Phase 2Results posted
• Atovaquone for Treatment of COVID-19CompletedNCT04456153Phase 2Results posted
• A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)TerminatedNCT04455815Phase 2Results posted
• VentaProst in Subjects With COVID-19 Requiring Mechanical VentilationCompletedNCT04452669Phase 2Results posted
• Safety and Efficacy of C21 in Subjects With COVID-19CompletedNCT04452435Phase 2Results posted
• COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR AssayCompletedNCT04452318Phase 3Results posted
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19CompletedNCT04449276Phase 1Results posted
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)CompletedNCT04448756Phase 2Results posted
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammationCompletedNCT04447469Phase 2/3Results posted
• Anti-Androgen Treatment for COVID-19CompletedNCT04446429Not applicableResults posted
• A Study of LAM-002A for the Prevention of Progression of COVID-19CompletedNCT04446377Phase 2Results posted
• Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive PatientsTerminatedNCT04445337Phase 1Results posted
• NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)TerminatedNCT04442230Phase 2Results posted

← COVID-19 overview